Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with the potential to replace this current cornerstone in the treatment of drug-resistant ...
Jul 9, 2025
0
21









